SCHEMBL2944207

SCHEMBL2944207

COc1c(F)c(F)c(-c2c3cc(F)c(F)cc3c(-c3c(F)c(F)c(F)c(F)c3F)c3cccc(F)c23)c(F)c1F

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TUBB4A P04350 4/20 0.32
TUBB P07437 4/20 0.32
TUBA3C P0DPH7 4/20 0.32
TUBA1B P68363 4/20 0.32
TUBA4A P68366 4/20 0.32
TUBB4B P68371 4/20 0.32
TUBB3 Q13509 4/20 0.32
TUBB2A Q13885 4/20 0.32
TUBB8 Q3ZCM7 4/20 0.32
TUBA3E Q6PEY2 4/20 0.32
TUBA1A Q71U36 4/20 0.32
TUBA1C Q9BQE3 4/20 0.32
TUBB6 Q9BUF5 4/20 0.32
TUBB2B Q9BVA1 4/20 0.32
TUBB1 Q9H4B7 4/20 0.32
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12086178 1.00 KDM4E (0.32) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB4A
SCHEMBL12086040 0.94 TUBB4A (0.31) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB4A
SCHEMBL2711033 0.94 TUBB4A (0.31) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB4A
SCHEMBL12086107 0.91 KDM4E (0.38) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB4A
SCHEMBL2710199 0.91 KDM4E (0.38) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB4A
SCHEMBL2942677 0.91 TSHR (0.32) ALDH1A1
SCHEMBL2712255 0.90
SCHEMBL2709659 0.89 ALDH1A1 (0.39) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB4A
SCHEMBL2712209 0.89 TUBB4A (0.32) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL2711106 0.89 CYP3A4 (0.39) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 KDM4E 670/4885ALDH1A1 34/4885MAPK1 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.